# WATCH-TAVR, WATCHMAN for Patients With Atrial Fibrillation Undergoing Transcatheter Aortic Valve Replacement

Study · id `cardio:ct-nct03173534` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT03173534](<https://clinicaltrials.gov/study/NCT03173534>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT03173534

Browse, organ or system: Heart  
Browse, condition area: Stroke; Heart rhythm problems; Valve and congenital heart disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 350 participants.

## Technical summary

Registry record NCT03173534. Randomized; no masking; primary purpose prevention. Start 2017-12-15 (actual); primary completion 2022-12-06 (actual). Results posted on 2024-05-22.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose prevention
- Phase: Not applicable
- Enrolled: 350 participants (enrolled count; ClinicalTrials.gov record NCT03173534, source copy `cardio:ctgov-nct03173534-2024-05-22`, retrieved 2026-10-26)
- Started: 2017-12-15 (actual) (ClinicalTrials.gov record NCT03173534, source copy `cardio:ctgov-nct03173534-2024-05-22`, retrieved 2026-10-26)
- Primary completion: 2022-12-06 (actual) (ClinicalTrials.gov record NCT03173534, source copy `cardio:ctgov-nct03173534-2024-05-22`, retrieved 2026-10-26)
- Completion: 2022-12-06 (actual) (ClinicalTrials.gov record NCT03173534, source copy `cardio:ctgov-nct03173534-2024-05-22`, retrieved 2026-10-26)
- Results first posted: 2024-05-22 (ClinicalTrials.gov record NCT03173534, source copy `cardio:ctgov-nct03173534-2024-05-22`, retrieved 2026-10-26)
- Countries: United States (ClinicalTrials.gov record NCT03173534, source copy `cardio:ctgov-nct03173534-2024-05-22`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct03173534-2024-05-22`, retrieved 2026-10-26)

## The registry's words

- Brief title: WATCH-TAVR, WATCHMAN for Patients With Atrial Fibrillation Undergoing Transcatheter Aortic Valve Replacement
- Condition: Atrial Fibrillation
- Condition: Aortic Valve Stenosis
- Intervention (Device): WATCHMAN
- Intervention (Device): TAVR
- Lead sponsor: samir kapadia
- Lead sponsor class: OTHER
- Collaborator: Boston Scientific Corporation
- Collaborator class: INDUSTRY
- Collaborator: The Cleveland Clinic
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Aortic stenosis (`cardio:aortic-stenosis`)
- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)
- Registry condition terms include this condition: Atrial fibrillation (AF) (`cardio:atrial-fibrillation`)
- Registry condition terms include this condition: Heart valve disease (`cardio:heart-valve-disease`)
- Registry intervention name matches this record: WATCHMAN left atrial appendage closure device (`cardio:watchman`)
- Registry lists this organization as a collaborator: Boston Scientific (`cardio:boston-scientific`)
- Registry lists this organization as a collaborator: The Cleveland Clinic (`cardio:org-the-cleveland-clinic`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Concomitant Left Atrial Appendage Occlusion and Transcatheter Aortic Valve Replacement Among Patients With Atrial Fibrillation (`cardio:pubmed-37874908`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 8a96dfcc0f1c74d98fc7709c5881fb5ef5919ac66ee41dbbbb03710508222c02
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
